Table 4.
Population | Best Target Exon | p-Value | Frequency (%) | Second Best Target | Frequency (%) |
---|---|---|---|---|---|
Australia | N/A | p = 0.11 | - | N/A | - |
Belgium | Exon 51 | p < 0.01 * | 10.26 | Exon 45 | 5.13 |
Bulgaria | Exon 51 | p < 0.01 | 17.39 | Exon 45 | 8.7 |
China | Exon 51 | p = 0.02 | 13.65 | Exon 53 | 7.94 |
Denmark | N/A | p = 0.67 | - | N/A | - |
France | N/A | p = 0.49 | - | N/A | - |
Germany | N/A | p = 0.15 | - | N/A | - |
Greece | Exon 51 | p < 0.01 | 20.22 | Exon 53 | 10.67 |
Hungary | Exon 51 | p < 0.01 | 11.82 | Exon 53 | 6.36 |
Italy | N/A | p = 0.96 | - | N/A | - |
Netherlands | N/A | p = 0.77 | - | N/A | - |
Portugal | Exon 51 | p < 0.01 * | 8 | Exon 45 | 6 |
Romania | Exon 51 | p < 0.01 | 19.35 | Exon 53 | 12.9 |
Serbia/ | Exon 45 | p < 0.01 | 11.27 | Exon 51 | 11.27 |
Mexico (this study) | N/A | p = 0.53 | - | N/A | - |
* Yate’s corrected p-value.